Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comprehensive Pathophysiological Study Based on the Core Neurocognitive Deficits and Development of Biological Markers of Treatment Response in Attention Deficit Hyperactivity Disorder

NCT02623114 is registered in ClinicalTrials.gov with Seoul National University Childrens Hospital as lead sponsor.

NCT NCT02623114
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02623114 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comprehensive Pathophysiological Study Based on the Core Neurocognitive Deficits and Development of Biological Markers of Treatment Response in Attention Deficit Hyperactivity Disorder
Lead sponsor
Seoul National University Childrens Hospital
Phase
Phase 4
Overall status
Unknown status
Start date
May 31, 2012
Completion date
March 31, 2017
Enrollment
400 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

attention-deficit/hyperactivity disorder